GALWAY, Ireland--(Healthcare Sales & Marketing Network)--Neuravi, a company dedicated to improving clinical outcomes for stroke patients, today announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available enhancements to the EmboTrap stent retriever platform, the EmboTrap® II Revascularization Device.
Neuravi has announced that Robert Colloton has joined the company’s senior management team as vice president of US Sales and Marketing.
The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy of the company’s next-generation stent retriever when used with Penumbra System aspiration devices compared to Penumbra System aspiration devices alone.
Relievant Medsystems has received US Food and Drug Administration (FDA) 510(k) clearance for the Intracept intraosseous nerve ablation system.
Among patients with one to three brain metastases, the use of stereotactic radiosurgery alone, compared with stereotactic radiosurgery combined with whole brain radiotherapy, resulted in less cognitive deterioration at three months, according to a study published in JAMA.
A study recently published in the journal Neuromodulation suggests that earlier consideration of spinal cord stimulation in chronic pain care continuum could have a positive impact on patient outcomes, with reductions in hospitalisations, clinic visits, and opioid usage.
In a report published online in the Lancet, investigators describe the results of the phase 1, first-in-man study of human neural stem cells in patients with chronic ischaemic stroke (PISCES study). In their study, Dheeraj Kalladka and others found that stem cell treatment was associated with improved neurological function and induced no cell-related adverse events.
The US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) to Monteris Medical to evaluate the NeuroBlate system in patients newly diagnosed with glioblastoma multiforme. With this approval, Monteris will initiate the Feasibility Study on Laser Interstitial Thermal Ablation for the Treatment of Newly Diagnosed GBM (FLAG), an open-label, prospective study that will be conducted in five sites in the USA.
Rapid Medical has announced that its Comaneci adjustable remodelling mesh has exceeded 500 successfully treated aneurysms worldwide. This milestone comes two years after the company launched the device in Europe.
Neuravi has received CE mark approval for newly available enhancements to its EmboTrap stent retriever platform, the EmboTrap II revascularisation device. The company will now launch the product in Europe, according to a press release.
The US Food and Drug Administration (FDA) has allowed marketing of two Trevo (Stryker Neurovascular) clot retrieval devices as an initial therapy for ischaemic strokes to reduce paralysis, speech difficulties and other stroke disabilities.
People with non-small cell lung cancer, whose disease has spread to the brain, could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet. The phase 3 randomised trial found that whole brain radiotherapy had no beneficial effect on length or quality of survival over treatment with steroids and other supportive care.
BALT International has announced that it has acquired Blockade Medical LLC, a privately held company focused on the development of catheter based therapeutic devices for the treatment of cerebral aneurysms. The terms of the acquisition were not disclosed.
A Wichita State University nursing faculty member, Wendy Dusenbury, has been invited to join an inaugural group of practitioners at the University of Tennessee to help test a one-of-a-kind mobile stroke unit. The specialised vehicle is the world’s largest mobile stroke unit and contains the most advanced computed tomography (CT) imaging capabilities ever in a mobile setting.
New University of British Columbia (Vancouver, Canada) research has found that amplified electroencephalograms can produce diagnostic results of cortical spreading depression that are comparable to placing electrodes directly to the surface of the brain, if a specially designed amplifier is used in tandem.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos